Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials

20241 citationsJournal Articlegreen Open Access

Authors

Julia Blanter · Icahn School of Medicine at Mount Sinai

Grace Van Hyfte · Icahn School of Medicine at Mount Sinai

Maham Ahmad · Yale University

Suzanne Xu · Johns Hopkins University

Olivia Hapanowicz · Icahn School of Medicine at Mount Sinai

Gabriela Fazilov · Icahn School of Medicine at Mount Sinai

Jiahua Lu

Abstract

Moderate FT was reported at baseline and on trial among EPCT participants. No change in FT was observed between time points. Additional efforts should be made to decrease FT associated with EPCT participation to maximize access to novel therapies.

Topics & Keywords

Economic and Financial Impacts of Cancer Health Systems, Economic Evaluations, Quality of Life Pancreatic and Hepatic Oncology Research

Publication Details

Published in: JCO Oncology Practice

Volume 21, Issue 6, pp. 862-875

DOI: 10.1200/op.24.00293

Field-Weighted Citation Impact: 1.13

Command Palette

Financial Toxicity Among Patients With Advanced Solid Tumors Participating in Early-Phase Clinical Trials

Authors

Abstract

Topics & Keywords

Publication Details